SignatureFD’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20K Hold
432
﹤0.01% 2345
2026
Q1
$10.6K Sell
432
-626
-59% -$14.8K ﹤0.01% 2485
2025
Q4
$26.2K Buy
1,058
+388
+58% +$10.3K ﹤0.01% 1991
2025
Q3
$19K Buy
670
+430
+179% +$11.7K ﹤0.01% 2136
2025
Q2
$5.97K Buy
+240
New +$6.76K ﹤0.01% 2542
2025
Q1
Sell
-19
Closed -$599 3472
2024
Q4
$599 Hold
19
﹤0.01% 3119
2024
Q3
$1.1K Hold
19
﹤0.01% 2982
2024
Q2
$771 Hold
19
﹤0.01% 2938
2024
Q1
$798 Hold
19
﹤0.01% 2977
2023
Q4
$728 Buy
+19
New +$633 ﹤0.01% 2942
2023
Q2
Sell
-55
Closed -$2.01K 3384
2023
Q1
$2.01K Buy
55
+27
+96% +$945 ﹤0.01% 2799
2022
Q4
$829 Buy
+28
New +$900 ﹤0.01% 3010
2022
Q1
Sell
-12
Closed -$1K 3352
2021
Q4
$1K Buy
12
+8
+200% +$657 ﹤0.01% 3023
2021
Q3
$0 Buy
+4
New +$340 ﹤0.01% 3239

Other funds holding ASTH

SignatureFD's ASTH Position: Q2 2026 in Review

SignatureFD held its Astrana Health (ASTH) position steady in Q2 2026 at 432 shares worth $20K. The position accounts for ﹤0.01% of the portfolio, ranked #2345.

SignatureFD first reported a position in ASTH in Q3 2021 and has held it in 14 quarters since. The position peaked at $26.2K in Q4 2025. 31 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • SignatureFD held 432 shares of Astrana Health worth $20K as of Q2 2026.
  • SignatureFD left its Astrana Health share count unchanged in Q2 2026.
  • Astrana Health made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #2345 holding.
  • SignatureFD first reported a position in Astrana Health in Q3 2021 and has held it in 14 quarters since.
  • SignatureFD's Astrana Health position peaked at $26.2K in Q4 2025.
  • 31 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.